TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Women’s healthcare Market
Chapter 5. Global Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
5.1. Global Women’s healthcare Market Share, By Type of Drug, 2015 - 2027 (USD Million)
5.1.1. EVISTA
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. XGEVA
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Prolia
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Zometa
5.1.4.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.5. Reclast
5.1.5.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.6. Minastrin
5.1.6.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
5.1.7. NuvaRing
5.1.7.1. Market Type and Projections,2015 - 2027 (USD Million)
5.1.7.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
6.1. Global Women’s healthcare Market Share, By application, 2015 - 2027 (USD Million)
6.1.1. Hormonal infertility
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Postmenopausal osteoporosis
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Endometriosis
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Contraceptives
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. Menopause
6.1.5.1. Market Type and Projections, 2015 - 2027 (USD Million)
Chapter 7. Global Women’s healthcare Market Overview, By Geography, 2015 - 2027(USD Million)
7.1. Global Women’s healthcare Market Share, By Geography, 2015 - 2027(USD Million)
7.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 8. North America Women’s healthcare Market Overview, By Countries, 2015 - 2027(USD Million)
8.1. North America Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
8.1.1. Market Type and projections, 2015 - 2027 (USD Million)
8.1.2. North America Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
8.1.3. North America Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
8.1.4. North America Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.4.1. U.S. Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
8.1.4.1.1. Market Type and projections, 2015 - 2027 (USD Million)
8.1.4.1.2. U.S. Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
8.1.4.1.3. U.S. Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
8.1.4.2. Canada Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
8.1.4.2.1. Market Type and projections, 2015 - 2027 (USD Million)
8.1.4.2.2. Canada Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
8.1.4.2.3. Canada Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
8.1.4.3. Mexico Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
8.1.4.3.1. Market Type and projections, 2015 - 2027 (USD Million)
8.1.4.3.2. Mexico Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
8.1.4.3.3. Mexico Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
Chapter 9. Europe Women’s healthcare Market Overview, By Countries, 2015 - 2027(USD Million)
9.1. Europe Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.2. Europe Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
9.1.3. Europe Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
9.1.4. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.4.1. Germany
9.1.4.1.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.4.1.2. Germany Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.1.3. Germany Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
9.1.4.2. France
9.1.4.2.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.4.2.2. France Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.2.3. France Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
9.1.4.3. UK
9.1.4.3.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.4.3.2. UK Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.3.3. UK Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
9.1.4.4. Italy
9.1.4.4.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.4.4.2. Italy Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.4.3. Italy Women’s healthcare Market Overview, By application 2015 - 2027(USD Million)
9.1.4.5. Spain
9.1.4.5.1. Market Type and projections, 2015 - 2027 (USD Million)
9.1.4.5.2. Spain Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.5.3. Spain Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
9.1.4.6. Rest of Europe
9.1.4.6.1. Market Type and projections, 2015 – 2027
9.1.4.6.2. Rest of Europe Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
9.1.4.6.3. Rest of Europe Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
Chapter 10. Asia Pacific Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Asia Pacific Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.2. Asia Pacific Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
10.1.3. Asia Pacific Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
10.1.4. Asia Pacific Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.4.1. India
10.1.4.1.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.4.1.2. India Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
10.1.4.1.3. India Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
10.1.4.2. China
10.1.4.2.1. Market Type and projections, 2015 - 2027(USD Million)
10.1.4.2.2. China Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
10.1.4.2.3. China Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
10.1.4.3. Japan
10.1.4.3.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.4.3.2. Japan Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
10.1.4.3.3. Japan Women’s healthcare Market Overview, By application, 2015 - 2027(USD Million)
10.1.4.4. South Korea
10.1.4.4.1. Market Type and projections, 2015 - 2027(USD Million)
10.1.4.4.2. South Korea Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
10.1.4.4.3. South Korea Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market Type and projections, 2015 - 2027 (USD Million)
10.1.4.5.2. Rest of Asia Pacific Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027(USD Million)
10.1.4.5.3. Rest of Asia Pacific Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
Chapter 11. Middle East & Africa Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Middle East & Africa Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.2. Middle East & Africa Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
11.1.3. Middle East & Africa Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
11.1.4. Middle East & Africa Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.4.1. GCC
11.1.4.1.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.4.1.2. GCC Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
11.1.4.1.3. GCC Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
11.1.4.2. South Africa
11.1.4.2.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.4.2.2. South Africa Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
11.1.4.2.3. South Africa Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market Type and projections, 2015 - 2027 (USD Million)
11.1.4.3.2. Rest of Middle East & Africa Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
11.1.4.3.3. Rest of Middle East & Africa Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
Chapter 12. South America Women’s healthcare Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. South America Women’s healthcare Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.2. South America Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
12.1.3. South America Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
12.1.4. South America Women’s healthcare Market Overview, By Countries, 2015- 2026 (USD Million)
12.1.5. Brazil
12.1.5.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.5.2. Brazil Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
12.1.5.3. Brazil Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
12.1.6. Argentina
12.1.6.1. Market Type and projections, 2015 - 2027 (USD Million)
12.1.6.2. Argentina Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
12.1.6.3. Argentina Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
12.1.7. Rest of South America
12.1.7.1. Market Type and projections, 2015 – 2027
12.1.7.2. Rest of South America Women’s healthcare Market Overview, By Type of Drug, 2015 - 2027 (USD Million)
12.1.7.3. Rest of South America Women’s healthcare Market Overview, By application, 2015 - 2027 (USD Million)
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2021
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Type development
Chapter 14. Key Vendor Analysis
14.1. Bayer AG
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Product Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Allergan
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Product Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Merck & Co.
14.3.1. Company overview
14.3.2. Financial performance
14.3.3. Product Benchmarking
14.3.4. Recent initiatives
14.4. Pfizer Inc
14.5. Amgen
14.6. Others
Chapter 15. Women’s healthcare Market Cost Analysis
15.1. Women’s healthcare Market Key Type Analysis
15.1.1. Key Type
15.1.2. Price Trend of Key Type
15.1.3. Key Suppliers of Type
15.1.4. Market Concentration Rate of Type
15.1.5. Labor Cost
Chapter 16. Sourcing Strategy and Downstream Buyers
16.1. Women’s healthcare Market Chain Analysis
16.2. Upstream Type Sourcing
16.3. Women’s healthcare Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Client
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Type
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Women’s healthcare Market share, By Type of Drug, 2020 & 2027 (%)
10. Global Women’s healthcare Market share, by EVISTA, By Type of Drug, 2015 - 2027 (USD Million)
11. Global Women’s healthcare Market share, by XGEVA, By Type of Drug, 2015 - 2027 (USD Million)
12. Global Women’s healthcare Market share, by Prolia, By Type of Drug, 2015 - 2027 (USD Million)
13. Global Women’s healthcare Market share, by Zometa, By Type of Drug, 2015 - 2027 (USD Million)
14. Global Women’s healthcare Market share, by Reclast, By Type of Drug, 2015 - 2027 (USD Million)
15. Global Women’s healthcare Market share, by Minastrin, By Type of Drug, 2015 - 2027 (USD Million)
16. Global Women’s healthcare Market share, by NuvaRing, By Type of Drug, 2015 - 2027 (USD Million)
17. Global Women’s healthcare Market share, By application, 2020 & 2027 (%)
18. Global Women’s healthcare Market share, by Hormonal infertility, By application, 2015 - 2027 (USD Million)
19. Global Women’s healthcare Market share, by Postmenopausal osteoporosis, By application 2015 - 2027 (USD Million)
20. Global Women’s healthcare Market share, by Endometriosis, By application 2015 - 2027 (USD Million)
21. Global Women’s healthcare Market share, by Contraceptives, By application 2015 - 2027 (USD Million)
22. Global Women’s healthcare Market share, by Menopause, By application 2015 - 2027 (USD Million)
23. Global Women’s healthcare Market share, by region, 2020 & 2027 (%)
24. Global Women’s healthcare Market share, by region, 2015 - 2027(USD Million)
25. North America Women’s healthcare Market, 2015 - 2027(USD Million)
26. North America Women’s healthcare Market share, by Countries, 2020 & 2027 (%)
27. U.S. Women’s healthcare Market, 2015 - 2027(USD Million)
28. Canada Women’s healthcare Market, 2015 - 2027(USD Million)
29. Mexico Women’s healthcare Market, 2015 - 2027(USD Million)
30. Europe Women’s healthcare Market, 2015 - 2027(USD Million)
31. Europe Women’s healthcare Market share, by Countries, 2020 & 2027 (%)
32. Spain Women’s healthcare Market, 2015 - 2027(USD Million)
33. UK Women’s healthcare Market, 2015 - 2027(USD Million)
34. Italy Women’s healthcare Market, 2015 - 2027(USD Million)
35. Germany Women’s healthcare Market, 2015 - 2027(USD Million)
36. France Women’s healthcare Market, 2015 - 2027(USD Million)
37. Rest of Europe Women’s healthcare Market, 2015 - 2027(USD Million)
38. Asia-Pacific Women’s healthcare Market, 2015 - 2027(USD Million)
39. Asia-Pacific Women’s healthcare Market share, by Countries, 2020 & 2027 (%)
40. China Women’s healthcare Market, 2015 - 2027(USD Million)
41. India Women’s healthcare Market, 2015 - 2027(USD Million)
42. Australia Women’s healthcare Market, 2015 - 2027(USD Million)
43. Japan Women’s healthcare Market, 2015 - 2027(USD Million)
44. Rest of Asia-Pacific Women’s healthcare Market, 2015 - 2027(USD Million)
45. Middle East & Africa Women’s healthcare Market, 2015 - 2027(USD Million)
46. Middle East & Africa Women’s healthcare Market share, by Countries, 2020 & 2027 (%)
47. GCC Women’s healthcare Market, 2015 - 2027(USD Million)
48. South Africa Women’s healthcare Market, 2015 - 2027(USD Million)
49. Rest Of Middle East & Africa Women’s healthcare Market, 2015 - 2027(USD Million)
50. South America Women’s healthcare Market, 2015 - 2027(USD Million)
51. Brazil Women’s healthcare Market, 2015 - 2027(USD Million)
52. Mexico Women’s healthcare Market, 2015 - 2027(USD Million)
53. Argentina Women’s healthcare Market, 2015 - 2027(USD Million)
54. Rest of South America Women’s healthcare Market, 2015 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Women’s healthcare Market, 2015-2027 (USD Million)
4. Women’s healthcare requirement, by country, 2015-2027, (USD Million)
5. North America Women’s healthcare Market, By Type of Drug, 2015-2027 (USD Million)
6. North America Women’s healthcare Market, By application, 2015-2027 (USD Million)
7. Europe Women’s healthcare Market, By Type of Drug, 2015-2027 (USD Million)
8. Europe Women’s healthcare Market, By application, 2015-2027 (USD Million)
9. Asia Pacific Women’s healthcare Market, By Type of Drug, 2015-2027 (USD Million)
10. Asia Pacific Women’s healthcare Market, By application, 2015-2027 (Revenue, USD Million)
11. Middle East & Africa Women’s healthcare Market, By Type of Drug, 2015-2027 (USD Million)
12. Middle East & Africa Women’s healthcare Market, By application, 2015-2027 (USD Million)
13. South America Women’s healthcare Market, By Type of Drug, 2015-2027 (USD Million)
14. South America Women’s healthcare Market, By application, 2015-2027 (USD Million)
15. Global Women’s healthcare Market, Company Market Share, 2020 - 2027 (%)
16. Bayer AG: Product Benchmarking
17. Bayer AG: Financial Performance
18. Allergan: Product Benchmarking
19. Allergan: Financial Performance
20. Merck & Co..: Product Benchmarking
21. Merck & Co..: Financial Performance
22. Pfizer Inc.: Product Benchmarking
23. Pfizer Inc.: Financial Performance
24. Amgen: Product Benchmarking
25. Amgen: Financial Performance
The Leading Key Players in Womens Healthcare Market
Bayer AG (Germany)
Allergan (Dublin)
Merck & Co. (US)
Pfizer Inc. (US)
Amgen (US)
Agile Therapeutics Inc. (US)
Ferring Pharmaceuticals (US)
Mylan N.V. (US)
Lupin (India)
Blairex Laboratories (US)
Apothecus Pharmaceutical (US).